Hepatitis B virus induces expression of cholesterol metabolism-related genes via TLR2 in HepG2 cells

World Journal of Gastroenterology

Volumn 19, Issue 14, 2013, Pages 2262-2269

  Li, Ying Ju ^a,b   Zhu, Ping ^c   Liang, Yu ^a   Yin, Wei Guo ^a   Xiao, Jian Hua ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b THE FIRST AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA   (China)

^c GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

3 hydroxy 3 methylglutharylcoenzyme A reductase; Hepatitis B virus; Lowdensity lipoprotein receptor; Toll like receptors

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CYTOTOXICITY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIMIT OF QUANTITATION; LIPID ABSORPTION; LIPID STORAGE; LIVER CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VIRUS GENOME; WESTERN BLOTTING;

EID: 84876387922     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i14.2262     Document Type: Article

References (30)

1. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 2011; 378: 571-583 [PMID: 21802134 DOI: 10.1016/S0140-6736(11)61097-0]
2. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virusinduced atherosclerosis. J Exp Med 1978; 148: 335-340 [PMID: 209124]
3. Bondini S, Kallman J, Wheeler A, Prakash S, Gramlich T, Jondle DM, Younossi ZM. Impact of non-alcoholic fatty liver disease on chronic hepatitis B. Liver Int 2007; 27: 607-611 [PMID: 17498244 DOI: 10.1111/j.1478-3231.2007.01482.x]
4. Targher G, Bertolini L, Padovani R, Rodella S, Arcaro G, Day C. Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. J Hepatol 2007; 46: 1126-1132 [PMID: 17335930 DOI: 10.1016/j.jhep.2007.01.021]
5. Kim K, Kim KH, Kim HH, Cheong J. Hepatitis B virus X protein induces lipogenic transcription factor SREBP1 and fatty acid synthase through the activation of nuclear receptor LXRalpha. Biochem J 2008; 416: 219-230 [PMID: 18782084 DOI: 10.1042/BJ20081336]
6. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, Muggeo M, Xu Q, Wick G, Poewe W, Willeit J. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001; 103: 1064-1070 [PMID: 11222467]
7. Ishizaka N, Ishizaka Y, Takahashi E, Toda EIE, Hashimoto H, Ohno M, Nagai R, Yamakado M. Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation 2002; 105: 1028-1030 [PMID: 11877348]
8. Wang JY, Liu P. Abnormal immunity and gene mutation in patients with severe hepatitis-B. World J Gastroenterol 2003; 9: 2009-2011 [PMID: 12970895]
9. Bzowska M, Nogieć A, Skrzeczyńska-Moncznik J, Mickowska B, Guzik K, Pryjma J. Oxidized LDLs inhibit TLR-induced IL-10 production by monocytes: a new aspect of pathogen-accelerated atherosclerosis. Inflammation 2012; 35: 1567-1584 [PMID: 22556042 DOI: 10.1007/ s110753-012-9472-3]
10. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511 [PMID: 15229469]
11. Wei XQ, Guo YW, Liu JJ, Wen ZF, Yang SJ, Yao JL. The significance of Toll-like receptor 4 (TLR4) expression in patients with chronic hepatitis B. Clin Invest Med 2008; 31: E123-E130 [PMID: 18544275]
12. Chen Z, Cheng Y, Xu Y, Liao J, Zhang X, Hu Y, Zhang Q, Wang J, Zhang Z, Shen F, Yuan Z. Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients. Clin Immunol 2008; 128: 400-408 [PMID: 18565796 DOI: 10.1016/ j.clim.2008.04.006]
13. Broering R, Lu M, Schlaak JF. Role of Toll-like receptors in liver health and disease. Clin Sci (Lond) 2011; 121: 415-426 [PMID: 21797822 DOI: 10.1042/CS20110065]
14. Zhang Y, Lian JQ, Huang CX, Wang JP, Wei X, Nan XP, Yu HT, Jiang LL, Wang XQ, Zhuang Y, Li XH, Li Y, Wang PZ, Robek MD, Bai XF. Overexpression of Toll-like receptor 2/4 on monocytes modulates the activities of CD4(+)CD25(+) regulatory T cells in chronic hepatitis B virus infection. Virology 2010; 397: 34-42 [PMID: 19945134 DOI: 10.1016/ j.virol.2009.11.007]
15. Wang YH, Chen YF, Chen SR, Chen X, Chen JW, Shen XY, Mou YG, Liu PQ. Aspirin increases apolipoprotein-A-Imediated cholesterol efflux via enhancing expression of ATP-binding cassette transporter A1. Pharmacology 2010; 86: 320-326 [PMID: 21088444 DOI: 10.1159/000321727]
16. Powell EE, Jonsson JR, Clouston AD. Steatosis: co-factor in other liver diseases. Hepatology 2005; 42: 5-13 [PMID: 15962320]
17. Ha HL, Shin HJ, Feitelson MA, Yu DY. Oxidative stress and antioxidants in hepatic pathogenesis. World J Gastroenterol 2010; 16: 6035-6043 [PMID: 21182217 DOI: 10.3748/wjg.v16. i48.6035]
18. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004; 114: 147-152 [PMID: 15254578]
19. Guedj H, Guedj J, Negro F, Lagging M, Westin J, Bochud PY, Bibert S, Neumann AU. The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirin. J Viral Hepat 2012; 19: 488-496 [PMID: 22676361 DOI: 10.1111/ j.1365-2893.2011.01569]
20. Roingeard P. Hepatitis C virus diversity and hepatic steatosis. J Viral Hepat 2013; 20: 77-84 [PMID: 23301542 DOI: 10.1111/jvh.12035]
21. Go GW, Mani A. Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis. Yale J Biol Med 2012; 85: 19-28 [PMID: 22461740]
22. Hofmann SL, Russell DW, Brown MS, Goldstein JL, Hammer RE. Overexpression of low density lipoprotein (LDL) receptor eliminates LDL from plasma in transgenic mice. Science 1988; 239: 1277-1281 [PMID: 3344433]
23. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990; 343: 425-430 [PMID: 1967820]
24. Geelen MJ, Gibson DM, Rodwell VW. Hydroxymethylglutaryl-CoA reductase--the rate-limiting enzyme of cholesterol biosynthesis. A report of a meeting held at Nijenrode Castle, Breukelen, The Netherlands, August 24, 1985. FEBS Lett 1986; 201: 183-186 [PMID: 3519281]
25. Medina MW, Gao F, Ruan W, Rotter JI, Krauss RM. Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin. Circulation 2008; 118: 355-362 [PMID: 18559695 DOI: 10.1161/CIRCULATIONAHA.108.773267]
26. Mason A, Wick M, White H, Perrillo R. Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection. Hepatology 1993; 18: 781-789 [PMID: 8406351]
27. Guillevin L. Virus-associated vasculitides. Rheumatology (Oxford) 1999; 38: 588-590 [PMID: 10461469]
28. Wu J, Lu M, Meng Z, Trippler M, Broering R, Szczeponek A, Krux F, Dittmer U, Roggendorf M, Gerken G, Schlaak JF. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology 2007; 46: 1769-1778 [PMID: 17929296]
29. Lian JQ, Wang XQ, Zhang Y, Huang CX, Bai XF. Correlation of circulating TLR2/4 expression with CD3+/4+/8+ T cells and Treg cells in HBV-related liver cirrhosis. Viral Immunol 2009; 22: 301-308 [PMID: 19811087 DOI: 10.1089/ vim.2009.0039]
30. Zhou Y, Zhu N, Wang X, Wang L, Gu LJ, Yuan WJ. The role of the toll-like receptor TLR4 in hepatitis B virus-associated glomerulonephritis. Arch Virol 2013; 158: 425-433 [PMID: 23076739]